BACKGROUNDAberrant activation of the β‐catenin signaling pathway has been implicated in several malignancies, including breast carcinoma. Recently, it was shown that p53 down‐regulated β‐catenin in a complex fashion. The authors examined the expression of β‐catenin, key members of its signaling pathway, and p53 in a large cohort of breast tumors.METHODSThe authors conducted an immunohistochemical analysis of the expression of β‐catenin, upstream modulators (HER‐2/neu, Met, and epidermal growth factor receptor [EGFR]), downstream target genes (cyclin D1 and matrix metalloproteinase‐7 [MMP7]), and p53 on a tissue microarray of 346 lymph node‐negative breast carcinomas. The results were correlated with one another and with standard clinicopathologic parameters.RESULTSβ‐Catenin expression was observed in the membrane and/or cytoplasm without any significant nuclear expression. HER‐2/neu and EGFR were observed on the membrane in 21% and 6% of tumors, respectively, and Met stained in a membrane/cytoplasm distribution in 28% of cases. Cyclin D1 was expressed in the nucleus and MMP7 was expressed in the cytoplasm in 26% and 75% of tumors, respectively. Nuclear expression of p53 was noted in 31% of tumors. When each marker was analyzed separately, only p53 and Met demonstrated a significant correlation with survival. However, patients who had tumors that coexpressed high levels of β‐catenin and p53 had markedly worse overall survival (P = 0.0026). In multivariate analysis, only tumor size, Met, and the coexpression of β‐catenin and p53 retained statistical significance.CONCLUSIONSThe current findings support a potential synergistic effect of abnormal β‐catenin regulation and p53 status in the pathogenesis and natural history of lymph node‐negative breast carcinoma. Furthermore, the results show that a combined analysis of multiple markers, notably β‐catenin and p53, may enhance the prognostic capabilities compared with individual markers. Cancer 2004. © 2004 American Cancer Society.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.